Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-03
DOI
10.1038/s41386-020-0628-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of the α7-Nicotinic Acetylcholine Receptor Agonist ABT-126 in the Treatment of Cognitive Impairment Associated With Schizophrenia
- (2018) George M. Haig et al. JOURNAL OF CLINICAL PSYCHIATRY
- The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: A critical and comprehensive review
- (2018) Ragy R. Girgis et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders
- (2018) Daniel C. Javitt et al. JAMA Psychiatry
- N -methyl- d -aspartate-type glutamate receptor modulators and related medications for the enhancement of auditory system plasticity in schizophrenia
- (2018) Joshua T. Kantrowitz SCHIZOPHRENIA RESEARCH
- The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development
- (2018) Andrew D. Krystal et al. NATURE REVIEWS DRUG DISCOVERY
- First in human trial of a type I positive allosteric modulator of alpha7-nicotinic acetylcholine receptors: Pharmacokinetics, safety, and evidence for neurocognitive effect of AVL-3288
- (2017) Kelvin W Gee et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Pharmacokinetic Limitations on Effects of an Alpha7-Nicotinic Receptor Agonist in Schizophrenia: Randomized Trial with an Extended-Release Formulation
- (2017) William R Kem et al. NEUROPSYCHOPHARMACOLOGY
- Alpha-7 nicotinic agonists for cognitive deficits in neuropsychiatric disorders: A translational meta-analysis of rodent and human studies
- (2017) Alan S. Lewis et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia
- (2017) Michael L. Thomas et al. JAMA Psychiatry
- The effects of glycine on auditory mismatch negativity in schizophrenia
- (2017) Lisa-Marie Greenwood et al. SCHIZOPHRENIA RESEARCH
- A tale of two sites: Differential impairment of frequency and duration mismatch negativity across a primarily inpatient versus a primarily outpatient site in schizophrenia
- (2017) Migyung Lee et al. SCHIZOPHRENIA RESEARCH
- Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms
- (2017) Joshua T. Kantrowitz et al. SCHIZOPHRENIA RESEARCH
- A Randomized Trial to Assess the Efficacy and Safety of ABT-126, a Selective α7 Nicotinic Acetylcholine Receptor Agonist, in the Treatment of Cognitive Impairment in Schizophrenia
- (2016) George M. Haig et al. AMERICAN JOURNAL OF PSYCHIATRY
- Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine
- (2016) Joshua T. Kantrowitz et al. BRAIN
- Derisking Psychiatric Drug Development
- (2016) Margaret C. Grabb et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Sensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia
- (2015) Daniel C. Javitt et al. AMERICAN JOURNAL OF PSYCHIATRY
- Social cognition in schizophrenia
- (2015) Michael F. Green et al. NATURE REVIEWS NEUROSCIENCE
- Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia
- (2015) Richard SE Keefe et al. NEUROPSYCHOPHARMACOLOGY
- Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia
- (2015) David Walling et al. SCHIZOPHRENIA BULLETIN
- Functional and Neuroanatomic Specificity of Episodic Memory Dysfunction in Schizophrenia
- (2015) J. Daniel Ragland et al. JAMA Psychiatry
- Understanding the Role α7 Nicotinic Receptors Play in Dopamine Efflux in Nucleus Accumbens
- (2014) Reinoud Maex et al. ACS Chemical Neuroscience
- Normalizing Effects of EVP-6124, an Alpha-7 Nicotinic Partial Agonist, on Event-Related Potentials and Cognition
- (2014) SHELDON H. PRESKORN et al. Journal of Psychiatric Practice
- A Randomized, Placebo-Controlled Study Investigating the Nicotinic α7 Agonist, RG3487, for Cognitive Deficits in Schizophrenia
- (2014) Daniel Umbricht et al. NEUROPSYCHOPHARMACOLOGY
- The novel α7 nicotinic acetylcholine receptor agonist EVP-6124 enhances dopamine, acetylcholine, and glutamate efflux in rat cortex and nucleus accumbens
- (2014) Mei Huang et al. PSYCHOPHARMACOLOGY
- α7-Nicotinic Acetylcholine Receptor Agonists for Cognitive Enhancement in Schizophrenia
- (2013) Robert Freedman Annual Review of Medicine
- A Randomized Exploratory Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) for Cognitive Enhancement in Schizophrenia
- (2013) Jeffrey A Lieberman et al. NEUROPSYCHOPHARMACOLOGY
- Auditory Emotion Recognition Impairments in Schizophrenia: Relationship to Acoustic Features and Cognition
- (2012) Rinat Gold et al. AMERICAN JOURNAL OF PSYCHIATRY
- From Perception to Functional Outcome in Schizophrenia
- (2012) Michael F. Green et al. ARCHIVES OF GENERAL PSYCHIATRY
- Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: A proof-of-mechanism study
- (2012) Georg Winterer et al. NEUROPHARMACOLOGY
- Neural correlates of relational and item-specific encoding during working and long-term memory in schizophrenia
- (2011) John D. Ragland et al. NEUROIMAGE
- Relational and Item-Specific Encoding (RISE): Task Development and Psychometric Characteristics
- (2011) John D. Ragland et al. SCHIZOPHRENIA BULLETIN
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now